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A B S T R A C T
β-Glucans are considered candidates for the medication in diﬀerent human pathologies. In this work, we have
puriﬁed β-glucan from a selected barley line and tested their eﬀects in primary human dermal ﬁbroblasts.
Unexpectedly, we have observed that this compound promoted a short-transitory proliferation arrest at 24 h
after its addition on the medium. We have determined that this transitory arrest was dependent on the cell-cycle
regulator protein Retinoblastoma. Moreover, dermal ﬁbroblasts increase their migration capacities at 24 h after
barley β-glucan addition. Also, we have described that barley β-glucan strongly reduced the ability of ﬁbroblasts
to attach and to spread on cell plates. Our data indicates that barley β-glucan signal induces an early response in
HDF cells favoring migration versus proliferation. This feature is consistent with our observation that the topical
addition of our barley β-glucan in vivo accelerates the wound closure in mouse skin.
1. Introduction
β-glucans are carbohydrate polymers that can be found in the cell
walls of many organisms such as bacteria, fungi, yeasts and some cer-
eals like barley and oat (Ahmad, Anjum, Zahoor, Nawaz, & Dilshad,
2012). Their structure consists of a polymer with glucose monomers
linked by glycosidic bonds in diﬀerent positions according to the or-
ganism: β-glucans from yeasts and fungi mainly contain linear β-(1→3)
chains or β-(1→3) with β-(1→6) linked side chains, whereas the
polymers derived from cereals have a β-(1→4) backbone interrupted by
separate β-(1→3) linkages. They show a great variability with respect
to molecular mass, and the diﬀerent linkages aﬀect signiﬁcantly water
solubility, viscosity, gelation capacity as well as physiological proper-
ties.
Many types of β-glucans possess a broad spectrum of protective
activities against adverse conditions and display important functions in
the modulation of immunological, anti-inﬂammatory and wound
healing responses. In general, they activate the immune system, and
stimulate defensive responses against pathogen infection (Lundahl,
Scanlan, & Lavelle, 2017), tumor development (Jin, Tang, Rong, &
Zhang, 2018), or wounding (Majtan & Jesenak, 2018). These eﬀects are
mediated through pattern recognition receptors (Borchers,
Krishnamurthy, Keen, Meyers, & Gershwin, 2008; Chan, Chan, & Sze,
2009; Ujita et al., 2009) located on target cells, predominantly mono-
cytes, macrophages, neutrophils, natural killer cells (Brown & Gordon,
2003; Lundahl et al., 2017), and also on skin cells such as keratinocytes
and ﬁbroblasts (Wei, Williams, & Browder, 2002).
Concerning to cereal β-glucans, the best characterized attribute is
the eﬀectiveness to reduce serum cholesterol levels (Abumweis, Jew, &
Ames, 2010) and post-prandial glycemic responses (Behall, Scholﬁeld,
Hallfrisch, & Liljeberg-elmståhl, 2006). Nonetheless, other systemic
responses have been described such as their immune modulating
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capacity (Chanput et al., 2012; Rieder & Samuelsen, 2012). In this way,
oat and barley β-glucans bind to dectin 1 receptor and interleukins and
alter the expression of inﬂammatory-associated genes and macrophage
activation (Tada et al., 2009; Volman et al., 2010). Also, barley β-
glucan has been described as a moderate to strong inducer of cytokine
production (Noss, Doekes, Thorne, Heederik, & Wouters, 2013). Ad-
ditionally cereal β-glucans protect from microbial infections (Estrada
et al., 1997; Yun, Estrada, Van Kessel, Park, & Laarveld, 2003), aﬀect
the viability of tumoral cells (Choromanska et al., 2018) and potentiate
the activity of antitumor monoclonal antibodies (Cheung, Modak, &
Vickers, 2002).
The protective eﬀect of β-glucans applies also to the skin barrier,
which is directly in contact with the environment. This property makes
the skin prone to the presence of wounds. To safeguard survival, our
organism has developed healing mechanisms to repair skin wounds and
to elude infections. Wound healing involves complex and overlapping
cellular events that can be assigned to any of three processes: in-
ﬂammation, proliferation and remodeling (Stadelmann, Digenis, &
Tobin, 1998). After wound, an immediate event is hemostasis and
generation of inﬂammatory stimuli. Then, activated macrophages pro-
duce growth factors and cytokines promoting anti-inﬂammatory and
antibacterial eﬀects, and also, the migration of dermal ﬁbroblasts to the
wound. In turn, those ﬁbroblasts proliferate in the wound and produce
extracellular matrix (ECM) components, such as collagen, to initiate the
remodeling process. In this scenario, β-glucans participate by activating
both immune and non-immune cells to stimulate wound repair (Kougias
et al., 2001; Majtan & Jesenak, 2018). For instance, (1→3),(1→6)-β-D-
glucans from fungi promote proliferation, migration and procollagen
secretion in human dermal ﬁbroblasts (HDF) and keratinocytes
(Majtán, Kumar, Koller, Dragúnová, & Gabriz, 2009; Son et al., 2007;
van den Berg, Zijlstra-Willems, Richters, Ulrich, & Geijtenbeek, 2014;
Wei et al., 2002; Woo et al., 2010).
The relevance of β-glucans on wound healing has also been tested in
clinical trials. For instance, topical application of yeast β-glucans im-
proves healing of diabetic and venous ulcers (Medeiros et al., 2012;
Zykova et al., 2014). In particular, for this kind of treatments, diﬀerent
laboratories are developing the preparation of porous membranes of
various biopolymers (Tamer et al., 2018; Woo et al., 2010).
Most eﬀects on wound healing have been found using linear o
branched β-glucans from fungi and yeast. However, up to date there is
little information regarding skin cell response after cereal β-glucans
exposure (Akkol et al., 2011; Du, Bian, & Xu, 2014). The purpose of this
investigation is the evaluation of the eﬀects of β-glucan (1→3),(1→4)
from barley on adult human dermal ﬁbroblasts in order to clarify the
action on wound healing in vitro and in vivo.
2. Materials and methods
2.1. Sample material
A hulled, waxy-endosperm, two-rowed barley line with high β-
glucan content (7.5%) has been used in this work as raw material. Seeds
were provided by Semillas Batlle S.A (Bell.lloc d’Urgell, Lleida, Spain)
2.2. Barley β-glucan extraction
The extraction in the Pilot Plant of the University of Lleida was
performed according to the procedure of Morgan 1998 (Morgan &
Ofman, 1998) with minor modiﬁcations. Brieﬂy, 2 kg of whole barley
grain were milled in a laboratory disk mill DLFU from Bühler Group.
Flour was suspended in 10 l of warm distilled water to reach 1:5 ﬂour/
solvent ratio. Mixture was stirred in a 50 l tank during 1 h with a
constant temperature of 55 °C. The solution was centrifuged using a
Beckman J2-21 centrifuge during 5min at 3000 rpm at 4 °C in order to
pellet the solid residue. The supernatant fraction was frozen at −20 °C
during 24 h and then thawed at room temperature. This solution was
ﬁltered through a 75 μm nylon mesh and β-glucan gels recovered. The
resulting extracts were rinsed with ultrapure water and freeze-dried.
2.3. Compositional analyses
Total β-glucan composition of dry powder extracts was determined
by the method of McCleary and Mugford (1997)) using the mixed
linkage β-glucan assay kit from Megazyme (Wicklow, Ireland) with
modiﬁcations for samples with high content of β-glucan.
2.4. Molecular weight determination
The molecular weight of barley β-glucan extracts was determined by
Gel Permeation Chromatography (GPC) using a chromatography
system, which consists of an isocratic pump (Waters 600 Waters,
Milford, MA), an automatic injector 717 Waters, a GPC column (PSS
SUPREMA, Analytical Ultrahigh, 8× 300mm, 10 μm) and a diﬀerential
refractive index detector Waters 2414. The column was kept at 35 °C
and the ﬂow rate of the mobile phase (NaNO3 100mM, NaN3 5mM)
was set at 0.6 ml min−1. Six diﬀerent molecular weight β-glucan
standards from Megazyme (Wicklow, Ireland) in the range of
35–650 kDa were dissolved in ultrapure water to obtain the calibration
curve.
2.5. FTIR-ATR spectroscopy
The FTIR-transmission spectra were recorded on a 6300 series Jasco
FT-IR equipped with a TGS detector by attenuated total reﬂectance
(ATR). Spectra were obtained by averaging 56 scans from 4000 cm−1 to
650 cm−1 at a resolution of 4 cm−1 and corrected for background ab-
sorbance by subtraction of the spectrum of the empty ATR crystal. FTIR
spectra were compared with pure barley β-glucan standard from
Megazyme (ref P-BGBL, 95% purity)
2.6. Cell culture
HDFa (adult Human Dermal Fibroblasts) were obtained from
Thermo Fisher Scientiﬁc (GIBCO, C0135C). Cells were maintained at
37 °C in a 5% CO2 incubator, and grown in Medium 106 (M106; GIBCO)
supplemented with Low Serum Growth Supplement (LSGS),
100 μgml−1 penicillin/streptomycin and 10 μgml-1 gentamicin. Barley
β-glucan was diluted in the medium at diﬀerent ﬁnal concentrations
always from a freshly prepared stock (10mgml−1). To prepare β-
glucan stock, 50 mg of powder was solubilized in 5ml of sterile water,
and the solution was heated and stirred in a water bath (90 °C) for
5min. Then, shaking was continued for 10min without heating. Methyl
cellulose (Sigma M7027) and Amylopectin (Sigma 10120) were solu-
bilized in water at room temperature following manufacturer's in-
structions (stock 10mgml−1).
2.7. Immunoblotting
For immunoblot, protein samples were resolved by SDS-PAGE,
transferred to PVDF membranes (Millipore), and incubated with pri-
mary antibodies anti-CyclinD1 (monoclonal DCS-6, Santa Cruz #sc-
20044, 1:200), anti-Cdk4 (polyclonal C-22, #sc-260, 1:250), anti-pho-
p38 (Thr180/Tyr182, monoclonal 28B10, Cell Signaling #9216,
1:500), anti-p38 (polyclonal, Cell Signaling #9212, 1:500), anti-Rb
(monoclonal G3-245, BD Pharmingen #554136, 1:500), anti-pho-Rb
(S780, monoclonal J146-35, BD Pharmingen #558385, 1:500), anti-
tubulin (monoclonal B-5-1-2, Sigma #T5168, 1:10000) and anti-actin
(monoclonal C4, Millipore #MAB1501R, 1:1000).
Appropriate peroxidase-linked secondary antibodies (GE Healthcare
UK Ltd) were detected using the chemiluminescent HRP substrate
Immobilon Western (Millipore). Chemiluminescence was recorded with
a ChemiDoc-MP imaging system (BioRad).
N.P. Fusté et al. Carbohydrate Polymers 210 (2019) 389–398
390
2.8. Proliferation assay
Three thousand HDFa cells per well were seeded on a 24-well plate
and treated with a ﬁnal concentration of 400 μgml−1 barley β-glucan
added to the growth medium. Control cells were untreated. After 24, 48
and 72 h of treatment cells were trypsinized, diluted in 300 μl of media
with Trypan Blue and counted in a Neubauer’s chamber.
2.9. Cell adhesion and spreading assays
Petri dishes were coated overnight at 4 °C with a 5 μg ml−1 solution
of ﬁbronectin (Invitrogen) in PBS or with 400 μgml-1 solution of barley
β-glucan. HDFa were trypsinized and seeded in serum-free medium in
uncoated, ﬁbronectin-coated, barley β-glucan-coated or ﬁbronectin-
barley-β-glucan double coated 35-mm-well plates. Seeded ﬁbroblasts
were incubated for 30 or 80min, and then, plates were washed with
PBS and ﬁxed with 4% paraformaldehyde for 15min at room tem-
perature. Total cells (adhered) were counted and the percentages of
spread cells were determined. Round and bright cells were considered
to be unspread.
2.10. Cell migration assay
HDFa cells were seeded on the bottom side of an 8.0-pore-size 6.5-
mm ﬁlter (Transwell, Corning) for 4 h in an incubator. Afterwards,
ﬁlters were loaded with M106 with LSGS and incubated in 24-well
plates containing LSGS-free M106 for 24 h. This protocol was per-
formed with or without 400 μgml−1 barley β-glucan (ﬁnal concentra-
tion) added to both media. Under these conditions, some cells migrate
from the bottom to the upper side of the ﬁlter. The remaining cells at
the bottom of the ﬁlter were removed with a cotton swab, and cells at
the upper-side were ﬁxed and stained with Hoescht. All cells
throughout the ﬁlter were counted with Image J software.
2.11. Bromodeoxyuridine (BrdU) incorporation assay
HDFa cells were seeded in a 24-well plate and treated with
400 μgml−1 barley β-glucan and control polymers for 24 h. For the last
8 h of treatment with β-glucan, 8 μg ml-1 BrdU were added. The same
was done with untreated cells that were used as a control. After 24 h,
ﬁbroblasts were ﬁxed with 4% PFA for 15min at room temperature.
Then, cells were permeabilized with 0.2% Triton-X-100 for 3min at
room temperature, washed with PBS, and successively treated with HCl
2M for 30min at 37 °C and with sodium tetraborate 0.1 M (pH 8.5) for
2min. Finally, preparation was blocked with 3% BSA. Anti-BrdU
(monoclonal BU1/75 (ICR1), Immunologicals Direct, #OBT0030,
1:200) was used with adequate Alexa488-labelled secondary antibody
(Molecular Probes) in PBS with 0.3% BSA. Nuclei were stained with
Hoechst (Sigma). Images were acquired using 40X and 60X objectives
in an Olympus FV1000 confocal system. Percentage of BrdU
Fig. 1. A. FTIR of both pure β-glucan standard from Megazyme (blue line) and barley β-glucan extract (red line) showing the same spectra. B. Structure of mixed-
linkage (1→3)(1→4) β-glucan. C. GPC plot of the β-glucan extract with a peak Mw of 64 kDa (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article).
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incorporation was obtained by counting green (BrdU-positive) and total
nuclei (Hoescht).
2.12. Wound closure assay
The procedure performed in this study followed the European Union
Guidelines for the Care and Use of Laboratory Animals, and it is ac-
cording to the Law 5/1995 and the Decree RD53/2013, which regulate
the use of animals for experimental and other scientiﬁc purposes
(Catalonian Government), and it was certiﬁed by the Ethics Committee
on Animal Experimentation from the University of Lleida (CEEA 03-03/
13).
C57BL/6 wild type mice were punched in their lumbar skin and
treated with water or a 30mgml−1 aqueous solution of barley β-glucan
for two weeks. Photos of the wound were taken every three days, and
the surface of the wound was estimated with Image J software.
3. Results
3.1. Characterization of the (1→3)(1→4)-β-D-glucan from barley grains
Total β-glucan content of lyophilized barley extract was determined
using the Megazyme mixed linkage β-glucans assay kit. Purity was more
than 95%, and similar to the Megazyme β-glucans standard.
Lyophilized barley β-glucan was analyzed by FTIR spectroscopy.
Fig. 1A shows three broad absorption bands: one at the 3338 cm–1 re-
gion that can be assigned to the hydroxyl stretching vibration of the
polysaccharide, indicating a strong OeH band; a second band at the
region between 1,318–1,420 cm–1, assigned to OH-bending; and a third
broad band for polysaccharides at 1200–800 cm–1. The peak between
2820 and 3000 cm–1 reﬂects a CeH stretching and, assigned to CH
groups. The main peak at 1035 cm–1 can be assigned to CeO bonds of
the alcohol groups. Peak shoulder at 1070 cm−1 and peak at 1154 cm−1
agree with the linear structure of β-glucan linked through 1–3 linkages
(Wang, Yao, Guan, Wu, & Kennedy, 2005). Also, peak at 894 cm–1 is
related to β(1–4) linkages (Zhang et al., 2018). These data agree with
peaks present in carbohydrates (Limberger-Bayer et al., 2014).
When the spectrum of the puriﬁed β-glucan used in this study (red
line) is compared with that of the pure β-glucan standard from
Megazyme (blue line)they fully overlap, which agrees with the purity
data obtained by spectrophotometric methods.
In Fig. 1C, the GPC plot of the β-glucan extract shows a main peak
with a retention time of 16.7 min and a Mw of 64 kDa. This agrees with
a low molecular weight β-glucan. There is also a second peak at
19.9 min, which corresponds to refractive index changes caused by
dead volume.
3.2. Barley β-glucan triggers a temporary proliferation arrest in human
dermal ﬁbroblasts
We have tested the eﬀects of puriﬁed barley β-glucan on the
proliferation of primary HDFs. Cells were cultured in the presence of
increasing concentrations of β-glucan, and cell number was determined
at diﬀerent time points. Unexpectedly, we observed a reduction in cell
number after 24 h of incubation, but not at longer incubation times, in
samples treated with a β-glucan concentration of 400 μg ml−1 (Fig. 2A).
Cells recovered their proliferation rate 48 h after β-glucan addition
(Fig. 2A and B). The number of dead cells was not signiﬁcant (fewer
than 1%) for all conditions independently of the treatment. These re-
sults suggested the existence of a short arrest in cell proliferation due to
the β-glucan addition. We conﬁrmed the existence of this arrest by
analyzing
BrdU incorporation. Control and β-glucan-treated HDF cells were
incubated with 10 μM BrdU for 8 h before processing the samples. The
levels of BrdU incorporated in the nucleus of the cells were determined
by immunoﬂuorescence (Fig. 2C). The percentage of BrdU-positive cells
was reduced at 24 h of β-glucan treatment as compared to untreated
cells, and it was clearly recovered by 48 h (Fig. 2D). In a similar ex-
periment, methylcellulose and amylopectin did not produce a sig-
niﬁcant reduction in the BrdU levels at 24 h treatment. Hence, barley β-
glucan induces a speciﬁc short arrest in the proliferation of human ﬁ-
broblasts.
Cell proliferation is ﬁnely regulated by the D-type cyclins (Ccnd)
and their partners: the cyclin-dependent kinases 4 and 6 (Cdk4/6).
Phosphorylation and subsequent inactivation of the retinoblastoma
protein (RB) by Ccnd-Cdk4/6 promotes cell cycle entry and prolifera-
tion. We determined by immunoblot the levels of Ccnd1 and Cdk4 in
barley β-glucan-treated ﬁbroblasts. We did not observe downregulation
of these proteins neither at 12 nor at 24 h after β-glucan addition
(Fig. 3A). Moreover, the total and phosphorylated levels of RB at serine
780 were not altered at 24 h after β-glucan addition (Fig. 3B). There-
fore, our results suggest that the proliferation arrest induced by barley
β-glucan in HDF cells is not dependent on the Ccnd1-Cdk4-RB axis.
However, Posas et al. (Gubern et al., 2016) have demonstrated that the
inactivation of RB due to the Cdks can be blocked when RB is phos-
phorylated by the stress-activated protein kinase p38. Then, to study
whether the proliferation arrest triggered by barley β-glucan was de-
pendent on RB, we knocked-down the levels of RB in HDF cells by RNA
interference (Fig. 3C). Cells expressing a shRNA against RB (shRB) or a
scramble shRNA as a control (scr) were treated with β-glucan for 24 h.
The proliferation rate was determined by BrdU incorporation. Treated
cells with low levels of RB showed a percentage of BrdU incorporation
similar to untreated cells (Fig. 3D). By contrast, treated cells expressing
normal RB levels showed a proliferation arrest. Therefore, our results
indicate that the proliferation arrest induced by barley β-glucan in HDF
cells is dependent on RB protein. In spite of this, barley β-glucan does
not produce a classical stress response in human ﬁbroblasts. Osmotic
stress triggers a rapid phosphorylation of the stress-activated protein
kinase p38 (Gubern et al., 2016). In agreement with this, the sudden
addition of NaCl to the medium caused a rapid phosphorylation of p38
in HDFa cells (Fig. 3E). However, we could not detect p38 phosphor-
ylation after β-glucan addition (Fig. 3E and F).
Fig. 2. Barley β-glucan triggers a short arrest in the proliferation of human ﬁbroblasts. A. The same number of HDF cells (104) was incubated with diﬀerent
concentrations of barley β-glucan, and cell count was determined at 24, 48 and 72 h after β-glucan addition. The values from three experiments are represented as the
mean ± sem. The diﬀerences of growth among concentrations at 24 h were signiﬁcant by one way ANOVA and Tukey-HSD post-test (*P < 0.05; **P < 0.01). B.
The same number of initial HDF cells was incubated 48 h in the absence of β-glucan. Then, cells were treated with 400 μg ml−1 of β-glucan and viable cells (trypan-
blue negative) were counted at 0, 24 and 48 h after β-glucan addition. Untreated cells were used as a control. The experiment was independently repeated three
times. Cell number is represented as mean ± sem. Signiﬁcance values were determined by one way ANOVA and Tukey-HSD post-test (**P < 0.01; ns, no sig-
niﬁcant). C. Representative images of BrdU staining. HDF cells were treated with 400 μg ml−1 of β-glucan and processed at 24 and 48 h after β-glucan addition.
Untreated cells were used as a control. Eight hours before processing, 10 μM BrdU was added to the medium. Cells were ﬁxed and processed for IF to detect BrdU
incorporation. D. Quantiﬁcation of BrdU staining of C. The percentage of BrdU-positive cells (mean ± sem) was obtained from three experiments. Signiﬁcance
values were determined by one way ANOVA and Tukey-HSD post-test (**P < 0.01). E. HDF cells were treated with 400 μg ml−1 of β-glucan, methylcellulose or
amylopectin, and processed at 24 h after compounds addition. Untreated cells were used as a control. Eight hours before processing, 10 μM BrdU was added to the
medium. Cells were processed as in C. The percentage of BrdU-positive cells (mean ± sem) was obtained from four independent experiments. Signiﬁcance values
were determined by one way ANOVA and Tukey-HSD post-test (*P < 0.05). BGN, β-glucan. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article).
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3.3. Barley β-glucan promotes migration and hinders cell adhesion in
human dermal ﬁbroblasts
Our data show that in the ﬁrst 24 h after barley β-glucan addition,
HDF cells have a transitory arrest in proliferation. Following our study,
we analyzed whether during this time β-glucan could induce other
biological eﬀects on these cells. First, we determined the contribution of
β-glucan to the ability of human ﬁbroblasts to migrate. To this purpose,
HDF cells were seeded on the bottom side of a transwell membrane in
the presence of medium without serum and with 400 μg ml−1 barley β-
glucan. Serum-supplemented medium containing 400 μg ml−1 β-
glucan was added to the upper side of the membrane. After 24 h of
incubation, the cells that had crossed the membrane to the upper side
were stained with Hoescht and counted (Fig. 4).
We observed that barley β-glucan treatment promoted ﬁbroblasts
migration (Fig. 4B). Thus, in the ﬁrst 24 h after β-glucan addition, ﬁ-
broblasts undergo a proliferation arrest but at the same time they im-
prove their migration ability.
A characteristic frequently associated to the migratory potential is
the ability of cells to disengage from the ECM (Gardel, Schneider,
Aratyn-Schaus, & Waterman, 2010). Thus, we reasoned that β-glucan
treatment could also aﬀect the ability of ﬁbroblasts to adhere and
spread on external surfaces. To test this, we seeded HDF cells on barley
β-glucan-coated plates and compared the spreading eﬃciency when
seeded on uncoated plates or on ﬁbronectin-coated plates. As expected,
Fig. 3. The proliferation arrest induced by barley β-glucan is dependent
on the retinoblastoma protein RB1. A. HDF cells were treated with β-glucan
for 12 and 24 h. Total Ccnd1 and Cdk4 levels were determined by immunoblot.
Untreated cells were used as a control. Actin was used as a loading control. B. In
the same cells, after 24 h of β-glucan addition, the levels of total and phos-
phorylated RB at serine 780 were determined by immunoblot. C. Cells were
infected with shRNA against RB (shRB1) or with a control shRNA (scramble;
scr). After 72 h the levels of RB were examined by immunoblot. st, loading
standard. D. The human ﬁbroblasts from C were seeded and treated with β-
glucan. After 24 h the proliferation rate was determined by BrdU incorporation.
The percentage of BrdU-positive cells (mean ± sem) was obtained from three
experiments. Untreated cells were used as a control. Signiﬁcance values were
determined by one way ANOVA and Tukey-HSD post-test (**P < 0.01). E. HDF
cells were grown for 48 h under normal conditions (con). These cells were
treated (con 0min) with 400 μg ml−1 of β-glucan (βGN) or 500mM NaCl. The
levels of P-Thr-180 p38 were determined 20min after treatment. Total p38 and
tubulin (tub) were used as a loading control. st, loading standard. F. Time
course showing the levels of P-Thr-180 p38 after β-glucan addition to human
ﬁbroblasts. Tubulin (tub) was used as a loading control.
Fig. 4. Barley β-glucan promotes migration of human ﬁbroblasts. A. HDF
cells were seeded in Transwell ﬁlters and allowed to migrate for 24 h with and
without β-glucan. To measure cellular migration, cells were ﬁxed, stained with
Hoescht and counted (migrated cells). Non-migrated cells were removed using a
cotton applicator. Representative images of the experiments are shown. B.
Quantiﬁcation of the experiments in A. The values are expressed as mean ±
sem. Data are from four experiments. Signiﬁcance of the values were de-
termined by the Mann-Whitney test (*P < 0.05).
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30min after seeding most ﬁbroblasts were spread on ﬁbronectin-coated
plates and a fraction of the cells on uncoated plates (Fig. 5A and B). By
contrast, the percentage of spread ﬁbroblasts in β-glucan-coated plates
was extremely low (Fig. 5B). Most ﬁbroblasts remained round and
bright on β-glucan coated plates (Fig. 5A). The addition of β-glucan in
the medium produced the same low eﬃciency of spreading after
seeding cells on uncoated plates (Fig. 5B). To test whether β-glucan
interfered in the interaction of cells with the ECM, we also analyzed the
spreading ability of the ﬁbroblasts in a double coating, ﬁbronectin and
β-glucan. This experiment showed that barley β-glucan does not in-
terfere in the adhesion of cells to ﬁbronectin (Fig. 5B). Next, we ana-
lyzed spreading and adhesion at longer times on uncoated and β-
glucan-coated plates. In these experiments, the presence of β-glucan
also reduced the eﬃciency of spreading (Fig. 5C) and adhesion
(Fig. 5D) of human dermal ﬁbroblasts.
3.4. Barley β-glucan accelerates wound closure in vivo
Our results suggest that barley β-glucan favors ﬁbroblasts migration
versus proliferation during an early period of the treatment. Since an
early response in the wound healing process is the migration of
ﬁbroblasts to the wound, we expected that barley β-glucan would im-
prove wound closure in vivo. To test this, a group of 10 C57BL/6 mice
were used in a wound-healing test. Two full-thickness dorsal wounds
were made on each mouse under general anesthesia and clean condi-
tions. One group of mice was topically treated with barley β-glucan
diluted in water (30mgml−1) every three days, and another group
(control) was treated in parallel but only with water. The wound re-
mained uncovered during all the treatment. Wound size measurements
were performed at ﬁve time points over 12 days. Fig. 6A shows re-
presentative images of wounds at diﬀerent times. In both groups of
mice, wounds were almost totally closed 12 days after their inﬂiction.
However, the speed at which wound closure took place was sig-
niﬁcantly increased in the barley β-glucan-treated group compared to
the control group (Fig. 6B). Hence, β-glucan produced and puriﬁed
from β-glucan-enriched barley grains is able to ameliorate the wound
healing process in vivo.
4. Discussion
In this work we show that barley β-glucan triggers a short pro-
liferation arrest in human dermal ﬁbroblasts, which appears to be in
Fig. 5. Barley β-glucan hinders ﬁbroblasts adhesion and spreading. A. HDF cells were trypsinized and seeded in serum-free medium on plates coated with 5 μg
ml−1 ﬁbronectin (FN) or 400 μg ml−1 β-glucan (BGN) or on uncoated plates. For double coating FN+BGN, a mixture of both solutions were used. For uncoated
plates, BGN was also added to the medium before seeding (added BGN). Thirty minutes after seeding, the proportion of spread cells was determined. Representative
images of HDFs seeded on ﬁbronectin and β-glucan. Arrows show ﬁbroblasts with spread morphology. B. Quantiﬁcation of the experiments in A. Data (mean ±
sem.) are from three experiments. Signiﬁcance values were determined by one way ANOVA and Tukey-HSD post-test (**P < 0.01). C. Percentage of spread HDF
cells at 80min after seeding on β-glucan-coated or uncoated plates. Values are expressed as mean ± sem from three experiments. Signiﬁcance of the values were
determined by t-test (**P < 0.01). D. Percentage of HDF cells attached to the plates at 80min after seeding on β-glucan-coated or uncoated plates. Values are
expressed as mean ± sem from three experiments. Signiﬁcance of the values were determined by t-test (**P < 0.01).
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contradiction with a previous report showing that β-glucans promote
cell proliferation in diﬀerent cell types (Majtan & Jesenak, 2018). To
reconcile these observations, we need to consider that barley β-glucan
induces time-dependent responses. At short term, 24 h after barley β-
glucan addition, we observed an arrest in proliferation, but we also
observed a complete recovery at 48 h. This β-glucan hallmark has not
been reported before because most works in the ﬁeld have analyzed β-
glucans long-term proliferation responses. However, data from at least
two diﬀerent reports invite to consider a negative eﬀect of fungal β-
glucan on the proliferation of HDFs and rat cells after 24 h of treatment
(Basha, Sampath Kumar, & Doble, 2017; Woo et al., 2010). At long
term, from 48 h onwards, barley β-glucan does not signiﬁcantly in-
crease proliferation in primary HDFs. By contrast, several published
works have shown that β-glucans promote long term cell proliferation
when used in a similar range of concentrations (Basha et al., 2017; van
den Berg et al., 2014; Woo et al., 2010). This contradictory result may
be explained by the various β-glucans used as well as by cell-type dif-
ferences. For example, it has been shown that (1→3),(1→6)-β-glucan
promotes long term cell proliferation in mouse connective tissue cells
(Son et al., 2005) but, as in our case, it does not change long term
proliferation in primary HDFs (Son et al., 2007). Thus, our conclusion is
that barley β-glucan can induce short term and long term responses on
the control of cell proliferation. In our primary ﬁbroblasts, barley β-
glucan triggers an RB-dependent short-term response and has no sig-
niﬁcant eﬀects on long term proliferation.
RB is a key negative regulator of cell cycle entry and proliferation.
This protein inhibits E2F, a major transcriptional regulator of the cell-
cycle gene network (Sherr, Roberts, Sherr, & Roberts, 2004). Cyclins D
and cyclin E complexed with their respective Cdks phosphorylate and
inactivate RB, releasing E2F function. Under osmotic stress conditions,
the activated-p38 kinase phosphorylates RB and bypasses de eﬀects of
Cdks, producing a proliferation arrest (Gubern et al., 2016). However,
this cannot account for the arrest we report here, because in our ex-
periments barley β-glucan did not trigger p38 activation neither at
shorter nor at longer times. Moreover, the proliferation arrest was not
detected after addition of other control polysaccharides such as me-
thylcellulose or amylopectin. Then, it is not a general shock response
due to the polysaccharide addition. Even though we cannot rule out
that other polysaccharides have the same eﬀect as β-glucan, we assume
that the response of HDFs to barley β-glucan depends on β-glucan-
speciﬁc receptors. At the moment, the signal pathways involved are
under study.
Barley β-glucan promotes cell migration in most cell types tested to
date (Majtan & Jesenak, 2018). Treating ﬁbroblasts with barley β-
glucan we have also conﬁrmed this phenotype. Cell movement requires
the coordination of various processes, and among them, the control of
cell adhesion is key. Concerning this, cells with better migration ca-
pacities show reduced cell–matrix attachment eﬃciencies (Li et al.,
2006; Neumeister, 2003). Since barley β-glucan promoted cell migra-
tion in HDF cells, we questioned whether it was involved in the control
of cell adhesion to the ECM. In our experiments, barley β-glucan did not
alter the spreading eﬃciency of HDF cells on ﬁbronectin-coated plates.
Fig. 6. Barley β-glucan improves wound closure in vivo. A. Appearance of the wounds in mice at 0, 3, 6, and 9 days after treatment with barley β-glucan or with
water as a control. B. Quantiﬁcation of the wound area. Values are expressed as mean ± sem from β-glucan-treated group (n= 9) and from untreated group (n=6).
Statistical signiﬁcance was determined by a two-way ANOVA test (β-glucan treatment p < 0.01; days p < 0.01) and Bonferroni posttests (*p < 0.05).
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It is well known that the interaction of membrane proteins such as in-
tegrins with ECM proteins such as ﬁbronectin triggers diﬀerent signal
pathways involved in the regulation of cell adhesion and spreading
(Huveneers & Danen, 2009). Then, barley β-glucan does not seem to be
a broad and major regulator of cell attachment to the ECM. However,
barley β-glucan reduced adhesion and spreading eﬃciencies of HDF
cells on treated-polystyrene plates. Then, this result suggests that β-
glucan is somehow also connected to the cell-surface attachment and
spreading processes. Further work will be required to elucidate whether
these phenotypes are a consequence of the physical interaction of
barley β-glucan with the plastic surface, or alternatively, β-glucan
causes speciﬁc anti-adherent responses through receptor-dependent
signaling.
5. Conclusions
β-glucans have a broad spectrum of eﬀects on diﬀerent cell types
that can explain their proﬁciency on healing (Majtan & Jesenak, 2018).
Moreover, diﬀerent clinical trials report that topical application of
fungal β-glucan ameliorates healing of diabetic and venous ulcers
(Medeiros et al., 2012; Zykova et al., 2014). In this work we contribute
new data showing that barley (1→3),(1→4) β-glucan induces an early
response in HDF cells favoring movement versus proliferation, and
accelerates wound closure in vivo. This is consistent with the wound
healing process whereby ﬁbroblasts initially migrate to the wound and
later proliferate and produce ECM (Stadelmann et al., 1998).
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